Vimian acquires UK allergy business

March 16, 2022

The Vimian Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health.

Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc. Avacta Animal Health provides veterinary allergy diagnostic solutions through its laboratory in Wetherby (UK) and re-sells Nextmune’s immunotherapy products to veterinary clinics across the UK. The business division also provides testing kits to veterinary laboratories in other European countries. The acquisition is a carve-out from AvactaGroup plc, a UK-based company focused on diagnostic solutions for human health.

The business had revenues of GBP 1.6 million in 2021.

Read more here.

Recent news

iBinder expands outside the Nordics

Swedish Software as a Service company iBinder develops and provides the construction and real estate industries with digital solutions for efficient collaboration. The company’s core solution is a cloud-based collaboration platform that ensures efficient and easy sharing of information throughout

Read more

Global property management group Odevo expands in…

Odevo, a portfolio company of Fidelio, has established itself in the US with KW Property & Management Consulting, a leading American property manager, joining the group. This marks both Odevo’s first step outside of Europe and its entry into the

Read more

Vimian raises 1.5bn in a directed share issue

Vimian Group delivers effective solutions for animals and veterinary professionals around the world. The Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Vimian is listed

Read more